| Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection (NCT03728426) | Amy C. Sherman, MD | 2019-01-11 |
| Feasibility and Safety of Additional Injection of Autologous Platelet-rich Stroma to Surgical Treatment of Rectovaginal Fistulas (NCT06798935) | Erasmus Medical Center | 2019-01-11 |
| Safety and Efficacy of FMT in Individuals With One or More Recurrences of Clostridium Difficile Associated Disease (CDAD) (NCT03548051) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-01-11 |
| Epigenetic Modulation of the immunE Response in GastrointEstinal Cancers (EMERGE) (NCT03812796) | Royal Marsden NHS Foundation Trust | 2019-01-11 |
| OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis (NCT03746483) | Entero Therapeutics | 2019-01-10 |
| Oral Use of Dexketoprofen/Tramadol for Acute Postoperative Pain in Total Hip Replacement With a Direct Anterior Approach. (NCT04178109) | KAT General Hospital | 2019-01-10 |
| Testing Insect Repellents Against Musca Sorbens, the Vector of Trachoma (NCT03813069) | London School of Hygiene and Tropical Medicine | 2019-01-10 |
| Impact of Minimally Invasive Restorative Techniques on Pregnant Women Oral Health Related Quality of Life (NCT04619264) | Nourhan M.Aly | 2019-01-10 |
| Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors (NCT03637803) | 4D pharma plc | 2019-01-10 |
| Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1 (NCT03630809) | H. Lee Moffitt Cancer Center and Research Institute | 2019-01-10 |
| A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX (NCT03450018) | British Columbia Cancer Agency | 2019-01-10 |
| The Impact of Minimally Invasive Restorative Techniques on Dental Pain in Pregnant Women (NCT04573608) | Nourhan M.Aly | 2019-01-10 |
| ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC (NCT04172259) | Sun Yat-sen University | 2019-01-10 |
| A Study on the Effectiveness of Antioxidant Supplementation in Tinnitus (NCT04105426) | National and Kapodistrian University of Athens | 2019-01-10 |
| PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury (NCT04054414) | Pharmazz, Inc. | 2019-01-10 |
| TIVA vs Inhalational Mode of Anaesthesia (NCT03807297) | Rajiv Gandhi Cancer Institute & Research Center, India | 2019-01-10 |
| Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF) (NCT03446612) | GlaxoSmithKline | 2019-01-10 |
| Anti Plaque Efficacy of Salvadora Persica L. and Green Tea Mouthwash (NCT03790904) | University of Baghdad | 2019-01-10 |
| Metformin Use in Rheumatoid Arthritis (NCT03863405) | Ain Shams University | 2019-01-09 |
| A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203) (NCT03679767) | Incyte Corporation | 2019-01-09 |
| Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma (NCT03331341) | University of Washington | 2019-01-09 |
| Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma (NCT03027388) | National Cancer Institute (NCI) | 2019-01-09 |
| Spironolactone Therapy In Young Women With NASH (NCT03576755) | University of California, San Francisco | 2019-01-09 |
| Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases. (NCT03869762) | Cancer Trials Ireland | 2019-01-09 |
| Effects of DHEA in Pulmonary Hypertension (NCT03648385) | Rhode Island Hospital | 2019-01-09 |
| A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB) (NCT03752905) | Phoenix Tissue Repair, Inc. | 2019-01-09 |
| Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib (NCT03778229) | AstraZeneca | 2019-01-09 |
| A Study of Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT (NCT04897880) | Australian & New Zealand Children's Haematology/Oncology Group | 2019-01-09 |
| Efficacy of Proanthocyanidins in Non-Surgical Periodontal Therapy (NCT05015387) | Lithuanian University of Health Sciences | 2019-01-09 |
| Pulsed Abraxane and Radiotherapy for Improving and Maintaining Ambulation After Cancer-Related Cord Compression (NCT03655080) | Washington University School of Medicine | 2019-01-09 |
| M6620 (VX-970) in Selected Solid Tumors (NCT03718091) | Massachusetts General Hospital | 2019-01-08 |
| The Efficacy of Bevacizumab Combined With m-FOLFOXIRI in Borderline Resectable Colorectal Liver Metastases (NCT03711240) | National Cheng-Kung University Hospital | 2019-01-08 |
| Jaktinib Hydrochloride Tablets in Intermediate-risk and High-risk Myelofibrosis. (NCT03886415) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2019-01-08 |
| Effects of Peer Mentoring on Caregivers of Patients With Acquired Brain Injury (NCT04851431) | Shepherd Center, Atlanta GA | 2019-01-08 |
| Wound Healing Endpoint and Recurrence (NCT02577120) | Sashwati Roy | 2019-01-08 |
| Care.Coach Avatars for Improvement of Outcomes in Hospitalized Elders, Including Mitigation of Falls and Delirium: a Multi-Site Clinical Study (NCT03832192) | Victor Wang | 2019-01-08 |
| Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC Adenocarcinoma (NCT03696212) | Arrys Therapeutics | 2019-01-08 |
| A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC) (NCT03595124) | National Cancer Institute (NCI) | 2019-01-08 |
| Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms (NCT03429075) | Imperial College London | 2019-01-07 |
| Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis (NCT03711448) | Centre Hospitalier Universitaire Dijon | 2019-01-07 |
| A Study to Evaluate the Safety and Tolerability of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus (NCT03745937) | MedImmune LLC | 2019-01-07 |
| Targeting the Tumor Microenvironment in R/M SCCHN (NCT03844763) | Gruppo Oncologico del Nord-Ovest | 2019-01-07 |
| A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study (NCT03844256) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2019-01-07 |
| Aggressive Antipyretics for Fever Reduction in CNS Malaria (NCT03399318) | University of Rochester | 2019-01-07 |
| L Brevis for Traumatic Oral Lesions in Orthodontic Patients (NCT04398511) | Universidade de Passo Fundo | 2019-01-07 |
| Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer (NCT03776487) | M.D. Anderson Cancer Center | 2019-01-07 |
| A Open-label, Single-arm, Multicenter, Phase II Study of RC48-ADC to Evaluate the Efficacy and Safety of Subjects With HER2 Overexpressing Locally Advanced or Metastatic Urothelial Cancer (NCT03809013) | RemeGen Co., Ltd. | 2019-01-07 |
| Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) (NCT03042143) | Belfast Health and Social Care Trust | 2019-01-07 |
| A PK/PD Study of CM4620-IE in Patients With Acute Pancreatitis (NCT03709342) | CalciMedica, Inc. | 2019-01-06 |
| Pupil Dilation for Treatment of IFIS (NCT03760185) | Denver Health and Hospital Authority | 2019-01-04 |
| Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2 (NCT03797001) | Virginia Commonwealth University | 2019-01-04 |
| rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temozolomide (NCT03687957) | Washington University School of Medicine | 2019-01-04 |
| Dabrafenib and Trametinib in Treating Patients With Erdheim Chester Disease With BRAF V600 Mutations (NCT03794297) | National Cancer Institute (NCI) | 2019-01-04 |
| 9-ING-41 in Patients With Advanced Cancers (NCT03678883) | Actuate Therapeutics Inc. | 2019-01-04 |
| The Role of Contrast Enhanced Ultrasound in Appendicitis (NCT03687502) | Children's Mercy Hospital Kansas City | 2019-01-04 |
| A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease. (NCT03776175) | Pfizer | 2019-01-04 |
| Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Development (NCT03780673) | Judit Pich | 2019-01-03 |
| LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma (NCT03773107) | Wake Forest University Health Sciences | 2019-01-03 |
| Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema (NCT03728504) | Asana BioSciences | 2019-01-03 |
| A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx, an Antisense Inhibitor Administered Subcutaneously to Hypertensive Participants With Controlled Blood Pressure (NCT03714776) | Ionis Pharmaceuticals, Inc. | 2019-01-03 |
| Pharmacokinetics of Oral Hydroxyurea Solution (NCT03763656) | Nova Laboratories Limited | 2019-01-03 |
| HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCC (NCT03803254) | Sun Yat-sen University | 2019-01-03 |
| Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease (NCT03587701) | Northwell Health | 2019-01-03 |
| A Study of Bevacizumab, Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (A-FOLFOXIRI) Compared With Bevacizumab, Infusional Fluorouracil, Leucovorin, and Irinotecan/Oxaliplatin (A-FOLFIRI/FOLFOX) as First-line Treatment for Metastatic Right-sided Colon Cancer (NCT03641976) | Yonsei University | 2019-01-03 |
| Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris. (NCT03752242) | BioMimetix JV, LLC | 2019-01-03 |
| Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS (NCT03703492) | University of Wisconsin, Madison | 2019-01-03 |
| A Study of PTC923 (CNSA-001) in Primary Tetrahydrobiopterin (BH4) Deficient Participants With Hyperphenylalaninemia (NCT03519711) | PTC Therapeutics | 2019-01-03 |
| Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer (NCT03649321) | University of Texas Southwestern Medical Center | 2019-01-03 |
| A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer (NCT03762161) | Rahul Parikh | 2019-01-03 |
| GRN-1201 With Pembrolizumab in Subjects With Metastatic PD-L1+ NSCLC (NCT03417882) | BrightPath Biotherapeutics | 2019-01-03 |
| Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache (NCT03781128) | University Hospital, Basel, Switzerland | 2019-01-02 |
| Nivolumab +/- Ipilimumab in Patients With Advanced, Refractory Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Tumors (NECs) (NCT03591731) | Intergroupe Francophone de Cancerologie Thoracique | 2019-01-02 |
| Postoperative Pain and Headache After Craniotomy (NCT03908944) | Steven Edelstein | 2019-01-02 |
| Onsite Buprenorphine Treatment at Syringe Exchange Programs (NCT03150173) | Montefiore Medical Center | 2019-01-02 |
| Antimicrobial Photodynamic Therapy Mediated by Papain Gel on Peri-Implantitis Lesions (NCT03753958) | University of Nove de Julho | 2019-01-02 |
| Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy (NCT03674411) | Masonic Cancer Center, University of Minnesota | 2019-01-02 |
| Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration (NCT04362449) | Imperial College Healthcare NHS Trust | 2019-01-02 |
| Efficacy and Safety of Polidocanol Foam 3% in the Treatment of II Degree Hemorrhoidal Disease (NCT03791775) | Societa Italiana di Chirurgia ColoRettale | 2019-01-02 |
| Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation (NCT03803436) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-01-02 |
| A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors (NCT03717415) | Deciphera Pharmaceuticals, LLC | 2019-01-02 |
| GLP1R in Parkinson's Disease (NCT03659682) | Oslo University Hospital | 2019-01-02 |
| Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT03188432) | Wake Forest University Health Sciences | 2019-01-02 |
| Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients. (NCT03737968) | Yonsei University | 2019-01-02 |
| Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma (NCT03749018) | David Bond, MD | 2019-01-02 |
| A Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic Subjects (NCT03622112) | AstraZeneca | 2019-01-02 |
| Nivolumab for Pediatric and Adult Relapsing/Refractory ALK+, for Evaluation of Response in Patients With Progressive Disease (Cohort 1) or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse (Cohort 2) (NCT03703050) | Gustave Roussy, Cancer Campus, Grand Paris | 2019-01-02 |
| Photobiomodulation Effects on Pain, Edema, Paresthesia and Bone Regeneration After Maxillar Surgical Disjunction (NCT03814525) | University of Nove de Julho | 2019-01-02 |
| Efficacy and Safety of 0.25% Timolol Gel in Enhancing Full Thickness Skin Grafts Healing and Cosmetic Outcomes (NCT03579160) | Brigham and Women's Hospital | 2019-01-02 |
| SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS (NCT03999437) | United Laboratories | 2019-01-02 |
| Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot Ulcers (NCT03754465) | Anterogen Co., Ltd. | 2019-01-02 |
| Preventing Diabetic Foot Ulcers Through Cleaner Feet (NCT03503370) | VA Office of Research and Development | 2019-01-02 |
| Effects of tDCS on Maximal Isometric Strength and Endurance Test of Trunk Extensors. (NCT03870178) | Universidade Federal do Piauí | 2019-01-02 |
| Propolis as a Treatment Option for Hand Foot and Mouth Disease (NCT06455007) | Murat Sutcu | 2019-01-01 |
| A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis (NCT03465111) | Metropolitan Eye Research & Surgery Institute | 2019-01-01 |
| Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma (NCT03904563) | Sun Yat-sen University | 2019-01-01 |
| Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in Children (NCT03868852) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2019-01-01 |
| Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia (NCT05631444) | Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle | 2019-01-01 |
| Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP (NCT05268692) | Kochi University | 2019-01-01 |
| Consolidative Radiotherapy Plus Maintenance Chemotherapy for Metastatic Colorectal Cancer (NCT03142282) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2019-01-01 |
| Efficacy and Safety of Anlotinib as Maintenance Treatment After First-line Chemotherapy in SCLC (NCT03780283) | First Hospital of Shijiazhuang City | 2019-01-01 |